Abstract
Germinogenous testicular tumors are a disease of young men of working age. The incidence rate is increasing every year and more often these tumors are found in developed countries. With the correct and timely diagnosis the effectiveness of treatment is close to 100%. For the diagnosis it is necessary to use immunohistochemical examination, which includes a wide panel of markers.References
Amin M.B., Edge S.B., Greene F.L. et al. AJCC Cancer Staging Manual. 8th ed // New York. - NY Springer, 2017.
Bahrami A., Ro J.Y, Ayala A.G. An overview of testicular GCTs// Arch Pathol Lab Med. - 2007. -Vol. 131. - P 1267-1280.
Boccellino M., Vanacore D., Zappavigna S. et al. Testicular cancer from diagnosis to epigenetic factors // Oncotarget. - 2017. - Vol. 8(61). - P 104654104663.
Chia V.M., Quraishi S.M., Devesa S.S. et al. International trends in the incidence of testicular cancer // Cancer Epidemiol Biomarkers. - 2010. - Vol.19(5). - P 1151-1159.
Greenlee R.T., Hill-Harmon M.B., Murray T. et al. Cancer statistics // CA Cancer J. Clin. - 2001. -Vol. 51. - P 15-36.
Koch S., Mayer F., Honecker F. et al. Efficacy of cytotoxic agents used in the treatment of testicular germ cell tumours under normoxic and hypoxic conditions in vitro // Br. J. Cancer. - 2003. -Vol. 89(11). - P. 2133-2139.
Maroto P., Anguera G., Martin C. Long-term toxicity of the treatment for germ cell-cancer // Oncology Hematology. - 2018. - Vol. 121. - P 62-67.
Moch H., Humphrey PA., Ulbright T.M. et al. WHO Classification of Tumors of the Urinary System and Male Genital Organs // International Agency for Research on Cancer. - Lyon, 2016.
Rosen A., Jayram G., Drazer M. et al. Global trends in testicular cancer incidence and mortality // Eur.Urol. - 2011. - Vol. 60(2). - P. 374-383.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
© АННМО «Вопросы онкологии», Copyright (c) 2018